Curative Biotechnology Valuation
| CUBT Stock | USD 0.01 0.0004 2.74% |
Curative Biotechnology seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Curative Biotechnology from analyzing the firm fundamentals such as Return On Equity of -3.98, current valuation of 14.46 M, and Shares Owned By Insiders of 0.05 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Curative Biotechnology's price fluctuation is out of control at this time. Calculation of the real value of Curative Biotechnology is based on 3 months time horizon. Increasing Curative Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Curative Biotechnology's intrinsic value may or may not be the same as its current market price of 0.01, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.015 | Real 0.0123 | Hype 0.0201 |
The intrinsic value of Curative Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Curative Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Curative Biotechnology helps investors to forecast how Curative stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Curative Biotechnology more accurately as focusing exclusively on Curative Biotechnology's fundamentals will not take into account other important factors: Curative Biotechnology Total Value Analysis
Curative Biotechnology is currently forecasted to have valuation of 14.46 M with market capitalization of 13.19 M, debt of 2.26 M, and cash on hands of 126.85 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Curative Biotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.46 M | 13.19 M | 2.26 M | 126.85 K |
Curative Biotechnology Investor Information
The company recorded a loss per share of 0.01. Curative Biotechnology had not issued any dividends in recent years. The entity had 1:400 split on the 2nd of December 2022. Based on the key measurements obtained from Curative Biotechnology's financial statements, Curative Biotechnology is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Curative Biotechnology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Curative Biotechnology has an asset utilization ratio of 5.08 percent. This implies that the Company is making $0.0508 for each dollar of assets. An increasing asset utilization means that Curative Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Curative Biotechnology Ownership Allocation
Curative Biotechnology holds a total of 903.26 Million outstanding shares. Almost 99.95 percent of Curative Biotechnology outstanding shares are held by general public with 0.051 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Curative Biotechnology Profitability Analysis
The company reported the previous year's revenue of 132.32 K. Net Loss for the year was (3.96 M) with profit before overhead, payroll, taxes, and interest of 100.21 K.About Curative Biotechnology Valuation
The stock valuation mechanism determines Curative Biotechnology's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Curative Biotechnology based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Curative Biotechnology. We calculate exposure to Curative Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Curative Biotechnology's related companies.Curative Biotechnology, Inc. operates as a development-stage biomedical company. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida. Curative Biotechnology operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Curative Biotechnology Growth Indicators
Investing in growth stocks can be very risky. If the company such as Curative Biotechnology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 662.2 M |
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.